مطالعۀ جالبی که اومده ارتباط اثرات سابجکتیو سایکدلیک‌ها با نتایج درمانیشون رو در دو مورد سایلوسایبین و کتامین بررسی کرده Our study demonstrated a modest role for subjective effects mediating therapeutic outcomes, with R2-values ranging from 5–10% for ketamine and for psilocybine the R2 was 24%. A greater mediating effect for psilocybin compared to ketamine was detected, particularly when restricting the analysis to depression. Additionally there is a greater mediating effect in SUD than depression, irrespective of treatment. nature.com/articles/s44184-024-00091-w 🧠 @NeuroINRP 🧠 Discussion group